Antineoplastics/furosemide/canrenoneLack of efficacy and dilated cardiomyopathy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70822-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：72 / 72

相关论文

共 50 条

[21] DopamineLack of efficacy during treatment of infantile dilated cardiomyopathy: case report
Reactions Weekly, 2020, 1829 (1) : 157 - 157
[22] Antineoplastics/prednisoloneLack of efficacy: case report
Reactions Weekly, 2024, 2031 (1) : 45 - 45
[23] Antineoplastics/pirarubicinLack of efficacy : case report
Reactions Weekly, 2022, 1921 (1) : 46 - 46
[24] Antineoplastics/posaconazoleLack of efficacy: case report
Reactions Weekly, 2024, 2039 (1) : 66 - 66
[25] Antineoplastics/DiureticsLack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 54 - 54
[26] Antineoplastics/CorticosteroidsLack of efficacy: case report
Reactions Weekly, 2021, 1869 (1) : 47 - 47
[27] BromocriptineFirst report of dilated cardiomyopathy: case report
Reactions Weekly, 2004, 1019 (1) : 7 - 7
[28] Antineoplastics/unspecified anaestheticTakotsubo cardiomyopathy syndrome: case report
Reactions Weekly, 2021, 1880 (1) : 59 - 59
[29] TacrolimusNonischaemic dilated cardiomyopathy: case report
Reactions Weekly, 2022, 1932 (1) : 542 - 542
[30] AnagrelideReversible dilated cardiomyopathy: case report
Reactions Weekly, 2015, 1536 (1) : 25 - 25

← 1 2 3 4 5 →